This Multibagger Pharma Giant’s Subsidiary Becomes First Fully NABL Accredited Company, Bags 2 Prestigious Awards for Diagnostic Excellence This Multibagger Pharma Giant’s Subsidiary Becomes First Fully NABL Accredited Company, Bags 2 Prestigious Awards for Diagnostic Excellence Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return is 171.38 per cent. DSIJ Intelligence-2 / Wednesday, April 23, 2025 / Article rating: 4.3 Over the past year, the stock has delivered a return of 27.39 per cent, while the three-year return is 171.38 per cent.
Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent Pharma Extends Crucial Support to Indices Amidst Broader Market Downturn, This Pharma Major Scaled Up 2.12 Per Cent The company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey DSIJ Intelligence / Monday, February 24, 2025 / Article rating: 4.5 The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey
Hot stock: This pharma company gets the green light from U.S. FDA for Fluocinolone Acetonide Topical Oil; stock rallies over 4 per cent! Hot stock: This pharma company gets the green light from U.S. FDA for Fluocinolone Acetonide Topical Oil; stock rallies over 4 per cent! The stock has witnessed significant buying activity as it has surged more than 65 per cent in the last 1 year. DSIJ Intelligence / Thursday, August 3, 2023 / Article rating: 4.0 The company has consistently maintained a robust dividend payout ratio of 18.2 per cent.
This global biotech company receives tentative approval from US FDA! This global biotech company receives tentative approval from US FDA! The company is committed to research and development, allocating 7.9 per cent of its revenue to this area in FY23. DSIJ Intelligence / Tuesday, July 4, 2023 / Article rating: 3.9 The company has delivered returns of 41.8 per cent over the past year.
This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! The company holds a leadership position in cardiovascular, anti-diabetic and respiratory segments and is the third-largest pharmaceutical company in the U.S. by prescriptions. DSIJ Intelligence / Monday, June 19, 2023 / Article rating: 4.0 A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, following the approval of its alliance partner Caplin Steriles Limited's ANDA by the U.S. FDA.
Overnight Digest: Stocks to keep an eye on April 13! Overnight Digest: Stocks to keep an eye on April 13! Watch out for these large-cap stocks in Thursday’s trading session! DSIJ Intelligence / Wednesday, April 12, 2023 / Article rating: 4.1 Watch out for these large-cap stocks in Thursday’s trading session!
Shares of this pharmaceutical company gained over 3 per cent after receiving approval from the USFDA Shares of this pharmaceutical company gained over 3 per cent after receiving approval from the USFDA Stock closed after a strong surge of 3.59 per cent from its previous day's close. DSIJ Intelligence / Wednesday, December 21, 2022 / Article rating: 4.2 Stock closed after a strong surge of 3.59 per cent from its previous day's close.
Overnight Digest: Stocks to keep an eye on December 12! Overnight Digest: Stocks to keep an eye on December 12! Watch out for these stocks in Monday’s trading session! DSIJ Intelligence / Saturday, December 10, 2022 / Article rating: 4.0 Watch out for these stocks in Monday’s trading session!
Overnight Digest: Stocks to keep an eye on November 22! Overnight Digest: Stocks to keep an eye on November 22! Watch out for these stocks in Tuesday's trading session! DSIJ Intelligence / Monday, November 21, 2022 / Article rating: 4.9 Watch out for these stocks in Tuesday's trading session!